T. Kleber-janke et al., Selective cloning of peanut allergens, including profilin and 2S albumins,by phage display technology, INT A AL IM, 119(4), 1999, pp. 265-274
Background: Peanut kernels contain many allergens able to elicit IgE-mediat
ed type 1 allergic reactions in sensitized individuals. Sera from sensitize
d patients recognize variable patterns of IgE-binding proteins. The identif
ication of the IgE-binding proteins of peanut extract would faciliate impro
vement of diagnostic and immunotherapeutic approaches as well as developmen
t of sensitive test systems for the detection of hidden peanut allergens pr
esent as additives in various industrial food products and the investigatio
n of their stability during processing of food products. Methods: We applie
d the pJuFo cloning system based on the phage surface display of functional
cDNA expression products to clone cDNAs encoding peanut allergens. Sera (n
= 40) of peanut-allergic individuals were selected according to case histo
ry, radioallergosorbent test and immunoblot analysis to demonstrate IgE bin
ding towards the newly identified recombinant allergens. Results: In additi
on to the known allergens Ara h 1 and Ara h 2 we were able to identify four
allergens with estimated molecular weights of 36, 16, 14.5 and 14 kDa. Thr
ee of them formally termed Ara h 4, Ara h6 and Ara h 7 show significant seq
uence similarities to the family of seed storage proteins and the fourth (A
ra h 5) corresponds to the well-known plant allergen profilin. Immunoblotti
ng of the six expressed recombinant allergens with 40 patients sera shows 1
4 individual recognition patterns and the following frequency of specific I
gE binding: Ara h 1 was recognized by 65%, Ara h 2 by 85%, Ara h 4 by 53%,
Ara h 5 by 13%, Ara h 6 by 38% and Ara h 7 by 43% of the selected sera. Con
clusions: All of the selected peanut-positive sera can detect at least one
of the six identified recombinant allergens which can be used to establish
individual patients' reactivity profiles. A comparison of these profiles wi
th the clinical data will possibly allow a further insight into the relatio
nship between clinical severity of the symptoms and specific IgE levels tow
ards the six peanut allergens.